Similar articles

• Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.

  Zannad F, Matzinger A, Larché J. Zannad F, et al. Am J Hypertens. 1996 Jul;9(7):633-43. doi: 10.1016/0895-7061(96)00021-0. Am J Hypertens. 1996. PMID: 8806975
• ACE inhibitors and calcium channel antagonists: a practical approach.

  McMahon JK, Briggs GC. McMahon JK, et al. Nurse Pract Forum. 1991 Mar;2(1):61-9. Nurse Pract Forum. 1991. PMID: 1840937 No abstract available.
• [The current therapy of hypertension].

  Magnani B. Magnani B. Cardiologia. 1991 Dec;36(12 Suppl 1):85-8. Cardiologia. 1991. PMID: 1841810 Review. Italian. No abstract available.
• Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?

  Bauer JH, Reams GP. Bauer JH, et al. J Am Soc Nephrol. 1990 Nov;1(5 Suppl 2):S80-7. J Am Soc Nephrol. 1990. PMID: 16989071 Review.
• Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

  Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Wald DS, et al. Am J Med. 2009 Mar;122(3):290-300. doi: 10.1016/j.amjmed.2008.09.038. Am J Med. 2009. PMID: 19272490